- Home
- RMBI vs XGN Comparison
RMBI vs XGN Comparison
Compare RMBI & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RMBI | XGN |
|---|---|---|
| Founded | 1887 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 132.9M | 138.0M |
| IPO Year | 2019 | 2019 |
Fundamental Metrics
Financial Performance| Metric | RMBI | XGN |
|---|---|---|
| Price | $13.94 | $5.06 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $13.67 |
| AVG Volume (30 Days) | 16.4K | ★ 405.8K |
| Earning Date | 01-23-2026 | 11-04-2025 |
| Dividend Yield | ★ 4.33% | N/A |
| EPS Growth | ★ 21.88 | N/A |
| EPS | ★ 1.06 | N/A |
| Revenue | $44,970,551.00 | ★ $63,599,000.00 |
| Revenue This Year | N/A | $21.76 |
| Revenue Next Year | N/A | $15.63 |
| P/E Ratio | $13.09 | ★ N/A |
| Revenue Growth | 6.42 | ★ 14.08 |
| 52 Week Low | $11.37 | $2.67 |
| 52 Week High | $15.24 | $12.23 |
Technical Indicators
Market Signals| Indicator | RMBI | XGN |
|---|---|---|
| Relative Strength Index (RSI) | 52.14 | 22.66 |
| Support Level | $13.86 | $5.74 |
| Resistance Level | $14.19 | $6.75 |
| Average True Range (ATR) | 0.20 | 0.43 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 56.66 | 10.30 |
Price Performance
Historical ComparisonAbout RMBI Richmond Mutual Bancorporation Inc.
Richmond Mutual Bancorp Inc is a United States-based banking company. Its principal business consists of attracting deposits from the general public & brokered deposits and investing those funds predominantly in loans secured by commercial and multi-family real estate, first mortgages on owner-occupied, one-to four-family residences, a variety of consumer loans, direct financing leases, and commercial and industrial loans. The company has one reportable segment which is Community Banking.
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.